Skip to main content
Image coming soon

Risk-Managed AI in Pharmaceutical R&D Operations for Compliance Officers

$199.00
Adding to cart… The item has been added

A tailored course, built for your situation

Risk-Managed AI in Pharmaceutical R&D Operations for Compliance Officers

Implementation-grade mastery for governance professionals navigating AI adoption in drug development

$199 one-time
24-hour access provisioning 30-day money-back guarantee Hand-built implementation playbook
12 modules. 12 chapters per module. 144 chapters total.
12 modules, each with 12 chapters (144 chapters total), text-based, plus downloadable templates and a hand-built implementation playbook delivered alongside course access.
AI is accelerating drug discovery, but unchecked deployment introduces compliance blind spots in validation, traceability, and oversight.

The situation this course is for

Compliance officers are increasingly asked to assess AI-driven R&D tools without clear frameworks, consistent validation methods, or operational playbooks. Traditional governance models don't address dynamic model behavior, data lineage in machine learning pipelines, or audit readiness for adaptive algorithms. This creates friction in approvals, delays in deployment, and increased scrutiny during inspections.

Who this is for

A senior compliance, quality assurance, or regulatory affairs professional in a pharmaceutical or biotech organization, responsible for evaluating, approving, or overseeing AI-integrated R&D systems.

Who this is not for

This course is not for data scientists building models, software engineers deploying infrastructure, or executives seeking high-level AI overviews without implementation detail.

What you walk away with

  • Apply risk-tiered frameworks to classify AI systems in R&D by compliance impact
  • Design audit-ready validation packages for machine learning models in clinical and preclinical settings
  • Implement data governance protocols specific to AI/ML training and inference pipelines
  • Lead cross-functional alignment between R&D, compliance, and IT on AI deployment standards
  • Develop real-time monitoring strategies for model drift, bias, and regulatory adherence

The 12 modules (with all 144 chapters)

Module 1. Foundations of AI in Pharmaceutical R&D
Introduce core AI/ML concepts within drug development contexts, including use cases, limitations, and regulatory expectations.
12 chapters in this module
  1. Overview of AI and machine learning in drug discovery
  2. Key differences between traditional software and adaptive AI systems
  3. Regulatory landscape shaping AI use in pharma
  4. Role of compliance in AI lifecycle governance
  5. Ethical considerations in AI-driven research
  6. Patient safety implications of algorithmic decision-making
  7. Integration points across preclinical and clinical development
  8. Common misconceptions about AI in regulated environments
  9. Data requirements for training and validation
  10. Defining scope and boundaries for AI projects
  11. Stakeholder mapping in AI-enabled R&D
  12. Establishing governance thresholds by risk level
Module 2. Regulatory Frameworks and AI Compliance
Examine current FDA, EMA, and ICH guidance relevant to AI, with emphasis on GxP alignment and inspection readiness.
12 chapters in this module
  1. Current FDA AI/ML guidance for medical devices and software
  2. EMA perspectives on AI in clinical trials and data analysis
  3. ICH Q9 principles applied to AI risk management
  4. GxP implications for AI in laboratory and manufacturing settings
  5. 21 CFR Part 11 and AI system validation
  6. Annex 11 compliance for AI-driven data processing
  7. Inspection trends and common findings in AI audits
  8. Aligning AI documentation with ALCOA+ principles
  9. Building regulatory dossiers for AI components
  10. Preparing for agency inquiries on algorithmic transparency
  11. Cross-border regulatory harmonization efforts
  12. Anticipating future policy developments in AI governance
Module 3. Risk Assessment and Tiering Models
Develop structured approaches to classify AI systems by risk level using science-based criteria and compliance impact scoring.
12 chapters in this module
  1. Principles of risk-based classification for AI
  2. Designing a risk matrix for pharmaceutical AI applications
  3. High-risk vs. low-risk AI use cases in R&D
  4. Impact scoring for patient safety and data integrity
  5. Likelihood assessment for model failure modes
  6. Using FMEA adapted for AI systems
  7. Tiering models for validation effort and oversight intensity
  8. Documenting risk rationale for audit purposes
  9. Reassessing risk throughout the AI lifecycle
  10. Handling uncertainty in model performance predictions
  11. Incorporating stakeholder input into risk decisions
  12. Benchmarking against industry risk frameworks
Module 4. AI Validation and Verification Protocols
Create robust validation strategies for AI models, including test design, performance metrics, and reproducibility standards.
12 chapters in this module
  1. Validation lifecycle for machine learning models
  2. Defining user requirements for AI systems
  3. Test planning and execution for AI components
  4. Performance metrics: accuracy, precision, recall, F1 score
  5. Cross-validation techniques and their limitations
  6. Bias detection and mitigation in training data
  7. Explainability methods for black-box models
  8. Reproducibility and version control for AI pipelines
  9. Challenge datasets and edge case testing
  10. Validation of real-time inference systems
  11. Documentation standards for AI validation reports
  12. Maintaining validation status during model updates
Module 5. Data Governance for AI Systems
Establish data integrity controls specific to AI, covering provenance, lineage, quality, and access management.
12 chapters in this module
  1. Data lifecycle management in AI projects
  2. Ensuring data provenance and audit trails
  3. Data quality metrics for training and validation sets
  4. Handling missing, imbalanced, or noisy data
  5. Data anonymization and privacy-preserving techniques
  6. Versioning datasets and tracking changes
  7. Access controls for sensitive R&D data
  8. Data retention and archival policies for AI
  9. Monitoring data drift over time
  10. Integrating data governance with AI model monitoring
  11. Compliance with data protection regulations
  12. Building data governance playbooks for AI teams
Module 6. Model Monitoring and Lifecycle Management
Implement continuous oversight of AI systems post-deployment, including drift detection, performance tracking, and update protocols.
12 chapters in this module
  1. Post-deployment monitoring requirements for AI
  2. Detecting model drift and concept drift
  3. Performance degradation thresholds and alerts
  4. Automated monitoring tools and dashboards
  5. Scheduled revalidation intervals
  6. Change control processes for model updates
  7. Rollback strategies for failed deployments
  8. Version management for models and pipelines
  9. Incident response planning for AI failures
  10. Audit logging for model behavior and decisions
  11. Human-in-the-loop oversight mechanisms
  12. Decommissioning AI systems securely
Module 7. Explainability and Audit Readiness
Ensure AI decisions are interpretable and defensible during audits, using transparency techniques and documentation standards.
12 chapters in this module
  1. Principles of algorithmic explainability
  2. Local vs. global interpretability methods
  3. SHAP, LIME, and other explainability tools
  4. Documentation for audit trails and decision logs
  5. Creating audit packages for AI systems
  6. Responding to inspector questions on model logic
  7. Balancing transparency with intellectual property
  8. Using surrogate models for explanation
  9. Visualizing model behavior for non-technical reviewers
  10. Regulatory expectations for explainability
  11. Handling unexplainable models in high-stakes settings
  12. Building trust through transparency
Module 8. Cross-Functional Governance Models
Design governance structures that align compliance, R&D, IT, and legal teams on AI deployment standards and accountability.
12 chapters in this module
  1. Establishing AI governance committees
  2. Defining roles and responsibilities across functions
  3. Developing AI charters and operating principles
  4. Escalation paths for compliance concerns
  5. Integrating AI governance into existing quality systems
  6. Change management for AI adoption
  7. Training programs for cross-functional teams
  8. Communication strategies for AI initiatives
  9. Managing vendor-developed AI systems
  10. Third-party audit coordination
  11. Performance metrics for governance effectiveness
  12. Continuous improvement of governance frameworks
Module 9. Vendor Management and Third-Party AI
Evaluate and oversee external AI providers, ensuring compliance alignment, data protection, and contractual safeguards.
12 chapters in this module
  1. Assessing vendor AI capabilities and maturity
  2. Due diligence for third-party AI solutions
  3. Contractual requirements for AI vendors
  4. Data ownership and usage rights in vendor agreements
  5. Audit rights and transparency clauses
  6. Service level agreements for AI performance
  7. Managing vendor lock-in and exit strategies
  8. Validation of vendor-provided models
  9. Oversight of cloud-based AI platforms
  10. Incident response coordination with vendors
  11. Ensuring regulatory compliance across supply chain
  12. Benchmarking vendor offerings against internal standards
Module 10. AI in Clinical Trial Design and Execution
Apply risk-managed AI to clinical development, including patient recruitment, endpoint prediction, and trial optimization.
12 chapters in this module
  1. AI applications in clinical trial protocol design
  2. Predictive modeling for patient enrollment
  3. Site selection optimization using machine learning
  4. Risk-based monitoring and anomaly detection
  5. Adaptive trial designs with AI support
  6. Endpoint prediction and surrogate biomarkers
  7. Real-world data integration in clinical AI
  8. Validation challenges for clinical AI models
  9. Regulatory considerations for AI in trials
  10. Informed consent and patient communication
  11. Monitoring safety signals with AI
  12. Documentation requirements for AI-augmented trials
Module 11. AI in Preclinical Research and Drug Discovery
Govern AI use in target identification, molecular design, and toxicity prediction with compliance rigor.
12 chapters in this module
  1. AI in target validation and pathway analysis
  2. Generative models for novel compound design
  3. Predicting ADMET properties with machine learning
  4. Toxicity screening and safety assessment models
  5. Validation of in silico toxicology tools
  6. Data standards for cheminformatics AI
  7. Reproducibility challenges in computational discovery
  8. Intellectual property considerations for AI-generated molecules
  9. Collaboration between computational and experimental teams
  10. Benchmarking AI predictions against wet-lab results
  11. Regulatory expectations for AI in early development
  12. Documentation for AI-driven discovery workflows
Module 12. Future-Proofing AI Governance in Pharma
Anticipate emerging trends, policy shifts, and technological advances to maintain long-term compliance resilience.
12 chapters in this module
  1. Emerging AI technologies in pharmaceutical R&D
  2. Anticipating regulatory evolution in AI oversight
  3. Preparing for AI-specific inspection modules
  4. Building organizational capability for AI governance
  5. Talent development and upskilling strategies
  6. Investment planning for AI compliance infrastructure
  7. Scenario planning for disruptive AI advances
  8. Engaging with standards bodies and consortia
  9. Contributing to industry best practices
  10. Measuring maturity of AI governance programs
  11. Scaling governance across global operations
  12. Sustaining compliance culture in AI-driven innovation

How this maps to your situation

  • Implementing AI validation in GxP environments
  • Preparing for regulatory inspections of AI systems
  • Leading cross-functional AI governance initiatives
  • Evaluating third-party AI tools for R&D adoption

Before vs. after

Before
Uncertain how to validate AI systems, classify risk, or prepare for audits in evolving regulatory environments.
After
Equipped with implementation-grade frameworks, templates, and playbooks to lead compliant AI integration in pharmaceutical R&D.

What's included with your purchase

  • 12 modules with 12 chapters each (144 chapters)
  • Downloadable templates and worked examples for every module
  • Hand-built implementation playbook delivered alongside course access
  • 30-day money-back guarantee

Delivery and format

  • Course and learning environment access provisioned within 24 hours of purchase
  • Hand-built implementation playbook delivered alongside course access

Format: Text-based modules and chapters in the Art of Service learning environment, plus downloadable templates and worked examples for every chapter, plus the hand-built implementation playbook delivered alongside course access.

Time investment: Approximately 45, 60 hours total, designed for flexible, self-paced learning with practical application exercises.

If nothing changes
Without structured governance, AI adoption in R&D may lead to inspection findings, delayed approvals, or operational disruptions due to unvalidated systems.

How this compares to the alternatives

Unlike high-level overviews or technical AI courses, this program delivers compliance-specific, implementation-ready knowledge tailored to pharmaceutical R&D contexts, with actionable templates and regulatory alignment strategies not found in generic AI governance training.

Frequently asked

Who is this course designed for?
Compliance, quality, and regulatory professionals in pharmaceutical or biotech organizations who need to evaluate, oversee, or govern AI systems in R&D.
How is the course structured?
12 modules, each containing 12 chapters (144 chapters total).
Is prior AI experience required?
No. The course includes foundational content and builds to advanced implementation topics, making it accessible to compliance professionals new to AI while still valuable for those with experience.
$199 one-time. Approximately 45, 60 hours total, designed for flexible, self-paced learning with practical application exercises..

Within 24 hours your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it.

30-day money-back guarantee· 144 chapters· Hand-built playbook included· Account access within 24 hours
!